Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Clin Microbiol Infect Dis ; 37(2): 371-380, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-29189980

RESUMO

Patients with diabetes mellitus have an increased risk of developing tuberculosis. Although the underlying mechanism is unclear, evidence suggests a role for chronic hyperglycaemia. We examined the influence of hyperglycaemia on Mycobacterium tuberculosis-induced cytokine responses in patients with type 1 diabetes mellitus (T1D). Peripheral blood mononuclear cells (PBMCs) from 24 male T1D patients with sub-optimal glucose control [HbA1c > 7.0% (53 mmol/L)] and from 24 age-matched male healthy controls were stimulated with M. tuberculosis lysate. Cytokine analysis, assessment of aerobic glycolysis, receptor recognition and serum cross-over experiments were performed to explore the mechanistic differences. PBMCs from T1D patients produced less bioactive interleukin (IL)-1ß in response to M. tuberculosis. IL-6 and interferon (IFN)-γ production trended towards a decrease, whilst other cytokines such as tumour necrosis factor (TNF)-α, IL-17 and IL-1Ra were normal. The decrease in cytokine production was not correlated to HbA1c or plasma glucose levels. Cross-over serum experiments did not alter the cytokine profile of T1D or control patients, arguing for an intrinsic cellular defect. Cellular metabolism and the expression of M. tuberculosis-related pattern recognition receptors (PRRs) such as TLR2, TLR4 and NOD2 did not differ between T1D patients and healthy controls. Compared to matched controls, T1D patients have a reduced capacity to produce pro-inflammatory cytokines in response to M. tuberculosis. The impaired IL-1ß production in T1D patients may contribute to the increased susceptibility to tuberculosis. This effect appears not to be related to prevailing glucose levels but to an intrinsic cellular deficit.


Assuntos
Diabetes Mellitus Tipo 1/imunologia , Suscetibilidade a Doenças/imunologia , Interleucina-1beta/biossíntese , Leucócitos Mononucleares/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose Pulmonar/epidemiologia , Glicemia , Glucose/metabolismo , Hemoglobinas Glicadas/análise , Humanos , Hiperglicemia/imunologia , Interferon gama/biossíntese , Proteína Antagonista do Receptor de Interleucina 1/biossíntese , Interleucina-17/biossíntese , Interleucina-6/biossíntese , Masculino , Pessoa de Meia-Idade , Tuberculose Pulmonar/microbiologia , Fator de Necrose Tumoral alfa/biossíntese
2.
Dtsch Med Wochenschr ; 139(19): 1009-14, 2014 May.
Artigo em Alemão | MEDLINE | ID: mdl-24782155

RESUMO

Sleep disordered breathing with predominant obstructive or central apnea is an under-recognized but highly prevalent comorbidity in patients with chronic heart failure. As the severity of heart failure increases the prevalence of central sleep apnea (CSA) and Cheyne-Stokes respiration (CSR) is also much more frequent. Cheyne-Stokes respiration is characterized by alternating periods of crescendo and decrescendo respiration followed by central apnea. Present data indicate that CSA-CSR is not only a compensatory response to severe heart failure but also a predictor of worse prognosis. However the results on long-term mortality are not consistent. The prognostic importance of night- and daytime CSR has to be further elucidated. Increased sympathetic nervous activity has been proposed to play a mayor role concerning progression and outcome of chronic heart failure by CSA-CSR.


Assuntos
Respiração de Cheyne-Stokes/diagnóstico , Insuficiência Cardíaca/diagnóstico , Apneia do Sono Tipo Central/diagnóstico , Idoso , Respiração de Cheyne-Stokes/mortalidade , Respiração de Cheyne-Stokes/fisiopatologia , Feminino , Insuficiência Cardíaca/mortalidade , Insuficiência Cardíaca/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade , Polissonografia , Prognóstico , Fatores de Risco , Apneia do Sono Tipo Central/mortalidade , Apneia do Sono Tipo Central/fisiopatologia , Taxa de Sobrevida , Disfunção Ventricular Esquerda/diagnóstico , Disfunção Ventricular Esquerda/mortalidade , Disfunção Ventricular Esquerda/fisiopatologia
3.
Brain ; 119 ( Pt 6): 2021-7, 1996 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9010006

RESUMO

Tumour necrosis factor (TNF)-alpha, a strong immune mediator, is released within the brain during inflammatory diseases and contributes to immunological activation of glial cells. Here we report that, in astrocytes, TNF-alpha also affects the intracellular Ca2+ homeostasis and basic electrophysiological properties such as the membrane potential. Using the Ca2+ indicator dye fura-2 in a cell culture model, we found that TNF-alpha (10-1000 U ml-1), but not interleukin 1 or 6, induced a slow but more than two-fold increase of the intracellular Ca2+ concentration, which could be blocked by Co2+ (1.0 mM), verapamil (100 microM) or omission of external Ca2+. This intracellular Ca2+ increase was accompanied by a marked decrease of the membrane potential by 35 mV. CSF of patients with bacterial meningitis, known to contain large amounts of TNF-alpha, induced a similar depolarization of astrocytes, which was markedly reduced by a neutralizing anti-TNF-alpha antibody. We conclude that TNF-alpha induces an increase of intracellular Ca2+ and a depolarization in astrocytes with the consequence of disturbing voltage-dependent glial functions such as regulation of local ion concentrations and glutamate uptake. During inflammatory CNS diseases this immuno-electrical coupling may contribute to an impairment of neuronal function.


Assuntos
Astrócitos/metabolismo , Cálcio/metabolismo , Potenciais da Membrana/fisiologia , Fator de Necrose Tumoral alfa/farmacologia , Animais , Líquido Cefalorraquidiano/fisiologia , Líquido Intracelular/metabolismo , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA